Cartesian Therapeutics, Inc. Annual Revenues in USD from 2014 to 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
Summary
Cartesian Therapeutics, Inc. annual/quarterly Revenues history and growth rate from 2014 to 2024.
  • Cartesian Therapeutics, Inc. Revenues for the quarter ending September 30, 2024 was $387K, a 94.1% decline year-over-year.
  • Cartesian Therapeutics, Inc. annual Revenues for 2024 was $38.9M, a 49.6% increase from 2023.
  • Cartesian Therapeutics, Inc. annual Revenues for 2023 was $26M.
  • Cartesian Therapeutics, Inc. annual Revenues for 2017 was $207K, a 97.4% decline from 2016.
Revenues, Trailing 12 Months (USD)
Revenues, Annual (USD)
Revenues, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $38.9M +$12.9M +49.6% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-13
2023 $26M Jan 1, 2023 Dec 31, 2023 10-K 2025-03-13
2017 $207K -$7.88M -97.4% Jan 1, 2017 Dec 31, 2017 10-K 2018-03-15
2016 $8.08M +$2.07M +34.5% Jan 1, 2016 Dec 31, 2016 10-K 2018-03-15
2015 $6.01M +$2.97M +97.7% Jan 1, 2015 Dec 31, 2015 10-K 2018-03-15
2014 $3.04M Jan 1, 2014 Dec 31, 2014 10-K 2017-03-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.